Antallet af patienter med moderat til svær nyreinsufficiens var for lavt til at bekræfte, at det er sikkert at anvende sitagliptin til denne type patienter.
The number of patients with moderate to severe renal insufficiency was too low to confirm safe use of sitagliptin in this type of patients.